BCL2 and small cell lung carcinoma: In our previous study, we conducted a BH3 mimetic screening, where SCLC cell lines were treated with selective inhibitors of BCL-2, BCL-xL and MCL-1 as well as a BCL-xL/2 dual inhibitor to determine their survival dependencies.